1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014" provides data on the Severe Acute Respiratory Syndrome (SARS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Severe Acute Respiratory Syndrome (SARS). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Severe Acute Respiratory Syndrome (SARS). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 5
Introduction 6
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Pharmstandard 29
Clinical Trial Overview of Pharmstandard 29
Hemispherx Biopharma, Inc. 30
Clinical Trial Overview of Hemispherx Biopharma, Inc. 30
Clinical Trial Overview of Top Institutes / Government 31
The National Institute of Allergy and Infectious Diseases 31
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 31
National Taiwan University Hospital 32
Clinical Trial Overview of National Taiwan University Hospital 32
Queen Mary Hospital 33
Clinical Trial Overview of Queen Mary Hospital 33
Hospital Authority 34
Clinical Trial Overview of Hospital Authority 34
Queen's University 35
Clinical Trial Overview of Queen's University 35
Five Key Clinical Profiles 36
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

List of Tables
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Region, 2014* 7
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Withdrawn Clinical Trials, 2014* 23
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmstandard, 2014* 29
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hemispherx Biopharma, Inc., 2014* 30
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 31
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 32
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital, 2014* 33
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2014* 34
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2014* 35

List of Figures
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 57

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.